1
Bernard Korol: Synthetic resin wound dressing and method of treatment using same. Paul M Denk, January 7, 1986: US04563184 (79 worldwide citation)

A synthetic resin wound dressing (e.g., a burn wound dressing) is disclosed consisting essentially of a polymer, such as poly(2-hydroxyethylmethacrylate), referred to as PHEMA, an organic solvent, such as polyethylene glycol (PEG), and a hydrogen binding plasticizer, such as dimethylsulfoxide (DMSO) ...


2
Bernard Korol: Synthetic resin matrix system for the extended delivery of drugs. Enquay Pharmaceutical Associates, Paul M Denk, May 31, 1988: US04747845 (65 worldwide citation)

A synthetic resin matrix system for the delayed and extended duration delivery of drugs to humans and animals is disclosed consisting of a polymer, such as poly(2-hydroxyethylmethacrylate), referred to as PHEMA, an organic solvent, such as polyethylene glycol (PEG), and a hydrogen binding plasticize ...


3
Bernard Korol, Paul Nathan: Anti-microbial sensitivity test and testing stratum. Enguay Pharmaceutical Associates, Paul M Denk, April 11, 1989: US04820292 (19 worldwide citation)

An anti-microbial sensitivity test and testing stratum is disclosed for evaluating the sensitivity of different anti-microbial agents relative to identifiable microbial contaminants. The test stratum comprises a polymer such as poly(2-hydroxyethylmethacrylate) referred to as PHEMA, an organic solven ...


4
Bernard Korol, Paul Nathan: Polymer matrices for storage and sustained release of drugs and chemicals. Pennie & Edmonds, November 6, 2001: US06312713 (18 worldwide citation)

Improved polymeric devices are disclosed which slowly and gradually release drugs or other chemicals, for use as wound dressings that gradually release antibiotics, analgesics, or other useful drugs directly onto the surfaces of wounds. These polymers also provide other sustained-release devices, su ...


5
Bernard Korol, Paul Nathan: Synthetic resin matrix system incorporating healing enhancer. Enquay Pharmaceutical Associates, August 15, 1989: US04857334 (14 worldwide citation)

An apparatus and method is described for applying epidermal growth factor (EGF) for achieving healing enhancement at a wound site. The human source of epidermal growth factor, designated as hEGF, is applied from the synthetic resin matrix system of this invention, and which comprises a polymer, such ...


6
Bernard Korol: Synthetic resin matrix drug storage and topical drug delivery dressing for veterinary usage. Enquay Pharmaceutical Associates, Paul M Denk, February 16, 1988: US04725271 (13 worldwide citation)

A synthetic resin matrix dressing is disclosed consisting essentially of a polymer, such as poly(2-hydroxyethylmethacrylate), referred to as PHEMA, an organic solvent, such as polyethylene glycol (PEG), and a hydrogen bonding plasticizer, such as dimethylsulfoxide (DMSO). The plasticizer regulates t ...